Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Vir Biotechnology, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 208
- +13 vs. Q3 2024
- Shares held
- 88.8M
- +2.74M (+3.2%) vs. Q3 2024
- Total value
- $652.0M
- +$7.45M (+1.2%) vs. Q3 2024
- New holders
- 42
- 69 more added
- Sold out
- 29
- 69 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 237 | $1.49B |
| Q1 2026 | 252 | $1.25B |
| Q4 2025 | 218 | $696.5M |
| Q3 2025 | 213 | $610.8M |
| Q2 2025 | 213 | $558.5M |
| Q1 2025 | 234 | $604.5M |
| Q4 2024 | 208 | $652.0M |
| Q3 2024 | 197 | $656.3M |
| Q2 2024 | 215 | $783.1M |
| Q1 2024 | 210 | $901.0M |
| Q4 2023 | 207 | $887.2M |
| Q3 2023 | 215 | $827.4M |
| Q2 2023 | 227 | $2.23B |
| Q1 2023 | 234 | $2.06B |
| Q4 2022 | 225 | $2.18B |
| Q3 2022 | 221 | $1.68B |
| Q2 2022 | 214 | $2.20B |
| Q1 2022 | 204 | $2.09B |
| Q4 2021 | 210 | $3.25B |
| Q3 2021 | 175 | $3.24B |
| Q2 2021 | 166 | $3.64B |
| Q1 2021 | 157 | $3.87B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1,807,017 | $13.3M | 0.00% | +720,690+66.3% | Added |
| Dimensional Fund Advisors LP | 1,915,465 | $14.1M | 0.00% | +703,360+58.0% | Added |
| Geode Capital Management, LLC | 2,196,601 | $16.1M | 0.00% | +7,827+0.4% | Added |
| OrbiMed Advisors LLC | 3,218,617 | $23.6M | 0.49% | −354,383−9.9% | Reduced |
| State Street Corp | 5,074,731 | $37.2M | 0.00% | −550,802−9.8% | Reduced |
| Vanguard Group Inc | 13,130,635 | $96.4M | 0.00% | −5,3210.0% | Reduced |
| BlackRock, Inc. | 16,462,717 | $120.8M | 0.00% | +86,911+0.5% | Added |
| SB Investment Advisers (UK) Ltd | 16,684,041 | $122.5M | 1.08% | 00.0% | Unchanged |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −2,383,029−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −1,085,210−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −350,265−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −220,821−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −196,991−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −102,400−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −97,948−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −68,113−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −52,276−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −41,891−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −35,132−100.0% | Sold out |
| Valence8 US LP | 0 | $0 | 0.00% | −33,650−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −32,862−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −26,400−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −22,455−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −19,719−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −16,435−100.0% | Sold out |
| Everence Capital Management Inc | 0 | $0 | 0.00% | −12,780−100.0% | Sold out |
| NorthCrest Asset Manangement, LLC | 0 | $0 | 0.00% | −11,700−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −11,170−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −10,587−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −3,989−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −485−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −391−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Bill & Melinda Gates Foundation | – | – | – | – | Not filed |
| FinTrust Capital Advisors, LLC | – | – | – | – | Not filed |